Elan Files Patent Suit Over Breast Cancer Drug

Law360, New York (July 20, 2006, 12:00 AM EDT) -- Looking to assert its patents for a lucrative breast cancer treatment, Irish drug manufacturer Elan Corp. has brought a patent infringement suit against a Los Angeles-based competitor.

Elan launched the lawsuit Wednesday in the U.S. District Court for the District of Delaware, claiming Abraxis Bioscience Inc. sells Abraxane in violation of its two patents that cover methods of making drugs to fight cancer.

Abraxis, a biopharmaceutical company created after American Pharmaceutical Partners and American BioScience merged, reported $134 million in sales for Abraxane in 2005, which...
To view the full article, register now.